Pediatrix Medical Group, Inc. (MD) stock
MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/307% above fair value
$31.40−0.05 (-0.16%)
Close on Nov 12, 2026Market cap $2.45BP/E 17.1Yield –
Pediatrix Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Pediatrix Medical's ebitda for the twelve months ending Sep 30, 2026 was $236.36M, up 6.3% year over year. For fiscal 2025 it was $230.64M. Over ten years it grew -9.4% a year on average. The highest annual figure on record is $660.95M in fiscal 2016.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $230.64M | – |
| FY2024 | Dec 31, 2024 | -$36.49M | -183.9% |
| FY2023 | Dec 31, 2023 | $43.49M | -79.1% |
| FY2022 | Dec 31, 2022 | $208.32M | -11.4% |
| FY2021 | Dec 31, 2021 | $235.07M | +85.7% |
| FY2020 | Dec 31, 2020 | $126.57M | -36.0% |
| FY2019 | Dec 31, 2019 | $197.69M | -27.5% |
| FY2018 | Dec 31, 2018 | $272.74M | -48.9% |
| FY2017 | Dec 31, 2017 | $533.75M | -19.2% |
| FY2016 | Dec 31, 2016 | $660.95M | +6.2% |
| FY2015 | Dec 31, 2015 | $622.10M | +11.3% |
| FY2014 | Dec 31, 2014 | $558.99M | +13.6% |
| FY2013 | Dec 31, 2013 | $492.10M | +17.1% |
| FY2012 | Dec 31, 2012 | $420.34M | +10.4% |
| FY2011 | Dec 31, 2011 | $380.68M | +13.7% |
| FY2010 | Dec 31, 2010 | $334.86M | +9.7% |
| FY2009 | Dec 31, 2009 | $305.38M | +19.6% |
| FY2008 | Dec 31, 2008 | $255.24M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $71.45M | -2.9% |
| Q2 FY2026 | Jun 30, 2026 | $62.70M | -3.8% |
| Q1 FY2026 | Mar 31, 2026 | $47.78M | +27.6% |
| Q4 FY2025 | Dec 31, 2025 | $54.43M | +17.9% |
| Q3 FY2025 | Sep 30, 2025 | $73.60M | +83.6% |
| Q2 FY2025 | Jun 30, 2025 | $65.18M | – |
| Q1 FY2025 | Mar 31, 2025 | $37.43M | +42.9% |
| Q4 FY2024 | Dec 31, 2024 | $46.16M | – |
| Q3 FY2024 | Sep 30, 2024 | $40.08M | -19.0% |
| Q2 FY2024 | Jun 30, 2024 | -$148.93M | -359.3% |
| Q1 FY2024 | Mar 31, 2024 | $26.20M | -32.8% |
| Q4 FY2023 | Dec 31, 2023 | -$102.43M | -326.7% |
| Q3 FY2023 | Sep 30, 2023 | $49.48M | -12.2% |
| Q2 FY2023 | Jun 30, 2023 | $57.44M | -2.5% |
| Q1 FY2023 | Mar 31, 2023 | $38.99M | -18.6% |
| Q4 FY2022 | Dec 31, 2022 | $45.17M | -40.5% |
| Q3 FY2022 | Sep 30, 2022 | $56.34M | -15.8% |
| Q2 FY2022 | Jun 30, 2022 | $58.93M | +1.4% |
| Q1 FY2022 | Mar 31, 2022 | $47.88M | +40.3% |
| Q4 FY2021 | Dec 31, 2021 | $75.86M | +89.7% |
| Q3 FY2021 | Sep 30, 2021 | $66.94M | +142.1% |
| Q2 FY2021 | Jun 30, 2021 | $58.12M | +40.7% |
| Q1 FY2021 | Mar 31, 2021 | $34.14M | +93.9% |
| Q4 FY2020 | Dec 31, 2020 | $40.00M | -15.3% |
| Q3 FY2020 | Sep 30, 2020 | $27.65M | -49.7% |
| Q2 FY2020 | Jun 30, 2020 | $41.32M | -16.2% |
| Q1 FY2020 | Mar 31, 2020 | $17.61M | -61.9% |
| Q4 FY2019 | Dec 31, 2019 | $47.25M | -62.8% |
| Q3 FY2019 | Sep 30, 2019 | $54.98M | -56.5% |
| Q2 FY2019 | Jun 30, 2019 | $49.29M | -65.4% |
| Q1 FY2019 | Mar 31, 2019 | $46.17M | -61.4% |
| Q4 FY2018 | Dec 31, 2018 | $126.99M | -16.5% |
| Q3 FY2018 | Sep 30, 2018 | $126.41M | -16.6% |
| Q2 FY2018 | Jun 30, 2018 | $142.67M | -3.4% |
| Q1 FY2018 | Mar 31, 2018 | $119.58M | -9.2% |
| Q4 FY2017 | Dec 31, 2017 | $152.12M | -9.5% |
| Q3 FY2017 | Sep 30, 2017 | $151.55M | – |
| Q2 FY2017 | Jun 30, 2017 | $147.64M | – |
| Q1 FY2017 | Mar 31, 2017 | $131.65M | – |
| Q4 FY2016 | Dec 31, 2016 | $168.03M | – |
See a number that looks wrong?